Sinai Hospital begins using first FDA-authorized AI diagnostic tool for sepsis

Sinai Hospital has started using Sepsis ImmunoScore®, the first FDA-authorized AI diagnostic tool for sepsis, which analyzes multiple clinical and laboratory measurements to predict sepsis risk within 24 hours. The tool integrates with electronic medical records to aid earlier diagnosis, potentially improving patient outcomes and reducing unnecessary treatments.

This Wire brief sits within Fusion42's coverage of Digital Health.